---
title: "Danaher slides 11% as biopharma order delays drag on outlook"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293388217.md"
description: "Danaher fell 11% in regular trading despite beating Q2 estimates, as biopharma order delays prompted a revenue guidance cut."
datetime: "2026-07-21T21:21:27.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293388217.md)
  - [en](https://longbridge.com/en/news/293388217.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293388217.md)
---

# Danaher slides 11% as biopharma order delays drag on outlook

丹纳赫 (DHR.US) 常规交易时段跌**10.99%**，现报**179.204 美元**，盘后微涨**0.11%**。该股盘中 5 分钟内急跌超 5%，短期波动剧烈。

消息面方面，丹纳赫公布 2026 年第二季度财报，营收**63 亿美元**、调整后每股收益**1.94 美元**均超预期，并上调全年 EPS 指引。生命科学业务表现强劲，但生物制药订单延迟导致 2026 年营收增长预测下调，拖累股价表现。

### Related Stocks

- [DHR.US](https://longbridge.com/en/quote/DHR.US.md)

## Related News & Research

- [Royal Bank of Canada Has $625.59 Million Position in Danaher Corporation $DHR](https://longbridge.com/en/news/294186660.md)
- [Stock Of The Day: Is The Danaher Selloff Over?](https://longbridge.com/en/news/293517409.md)
- [AMG National Trust Bank Buys 7,041 Shares of Danaher Corporation $DHR](https://longbridge.com/en/news/292580147.md)
- [Key facts: Danaher strong cash; trims 2026 outlook; bio orders, $100M deferred](https://longbridge.com/en/news/293434927.md)
- [Danaher unit Cepheid unveils third-generation GeneXpert system at ADLM 2026](https://longbridge.com/en/news/293477376.md)